GA - GAC
Rules and Regulations of the State of Georgia
Terms and Conditions of Agreement for Access to Rules and Regulations of the State of Georgia Website

(Note: certain features of this site have been disabled for the general public to prevent digital piracy. If you are an entitled government entity pursuant the Georgia Administrative Procedures Act, O.C.G.A.§ 50-13-7(d) contact the State of Georgia's Administrative Procedures Division at 678-364-3785 to enable these features for your location.)

To access this website, you must agree to the following:

These terms of use are a contract between you and/or your employer (if any), and Lawriter, LLC.

You agree not to use any web crawler, scraper, or other robot or automated program or device to obtain data from the website.

You agree that you will not sell or license anything that you download, print, or copy from this website.

THIS WEBSITE AND ITS CONTENT ARE PROVIDED "AS IS." THE STATE OF GEORGIA AND LAWRITER EXPRESSLY DISCLAIM ALL WARRANTIES, INCLUDING THE WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT AND ARE NOT LIABLE TO ANY PERSON FOR ANY ERRORS IN INACCURACIES CONTAINED IN THIS WEBSITE.

By accessing and/or using this website, you agree to the terms and conditions above. If you do not agree to the terms and conditions above, you must cease accessing and/or using this website and destroy all material obtained from this website without your agreement.

If you accept these terms enter the information below and click “I AGREE”.

Chapter 480-27 REQUIREMENTS OF A PRESCRIPTION DRUG ORDER WHEN UTILIZING A COMPUTER OR OTHER ELECTRONIC MEANS

Rule 480-27-.01 Definitions

For purposes of these Rules and Regulations, the following definitions apply:

(a) Authentication. Any process by which the identities of the parties sending and receiving electronic prescription data are verified.
(b) Automated Electronic Data Processing System. A system utilizing computer software and hardware for the purpose of record-keeping and/or receiving prescription drug orders. Any and all such systems that are compatible and capable of interacting with, and electronically transferring prescription drug data with any other system must be in compliance with the rules of the Board for use in electronic prescription monitoring.
(c) Board. The Georgia State Board of Pharmacy.
(d) Computer. Programmable electronic device capable of multifunctions including but not limited to storage, retrieval and processing of information.
(e) Controlled Substances. Those drug items regulated by federal law and/or the Georgia Controlled Substances Act.
(f) Dangerous Drugs. Those drug items and devices regulated by the Georgia Dangerous Drug Act.
(g) Digital ID. An authenticated identifiable signature than can be attached to an electronic e-mail and is tamper proof.
(h) Downtime. That period of time when a computer is not operable.
(i) Electronic Means. An electronic device used to send, receive, and/or store prescription drug order information, including computers, facsimile machines, etc.
(j) Electronic Signature. An electronically reproduced visual image signature or an electronic data signature of a practitioner, which appears on, is attached to or is logically associated with an electronic prescription drug order.
(k) Facsimile. A hard copy prescription drug order sent via a facsimile machine.
(l) Hard Copy. A fileable prescription drug order which is written or printed via electronic means.
(m) Hardware. The fixed component parts of a computer.
(n) HIPPA. The Health Insurance and Portability and Accountability Act and the associated security standards for the protection of electronic protected health information.
(o) Intervening Electronic Formatter. An entity that is not prohibited under O.C.G.A. Section 26-4-80(c)(1) and (5), and that provides the infrastructure that connects a computer or automated electronic data processing system or other electronic device used by a prescribing practitioner with a computer or automated electronic data processing system or another electronic device used by the pharmacy to facilitate the secure transmission of:
1. An electronic prescription drug order;
2. A refill authorization request;
3. A communication; and
4. Other patient care information between a practitioner and pharmacy.
(p) NPI. National Provider Standard Identifier.
(q) Practitioner Drug Order. A drug order written in an institutional practice/setting in a patient's chart for a specific patient. It is not necessary to reduce to writing as required for a prescription drug order.
(r) Prescriber. A practitioner authorized to prescribe and acting within the scope of this authorization.
(s) Prescription Drug Order. A lawful order from a practitioner, acting within the scope of his or her license to practice, for a drug or device for a specific patient. Such order includes a written order from the practitioner, a telephone order reduced to writing by the pharmacist, and electronic image prescription drug order and an electronic data prescription drug order.
(t) Print-out. A hard copy document generated by computer or other electronic means that is readable without the aid of any special device.
(u) Regulatory Agency. Any federal or state agency charged with enforcement of pharmacy or drug laws and regulations, i.e., the Georgia Drugs and Narcotics Agency (GDNA), the Drug Enforcement Administration (DEA), or the Georgia Department of Medical Assistance (Medicaid).
(v) Security Paper. Paper with security features on which the electronic visual image prescription drug order of a practitioner is printed and presented to a patient so as to ensure that a prescription drug order is not subject to any form of copying, reproduction, or alteration, and may include a watermark produced by the electronic digital process when a prescription is printed that clearly shows if a prescription has been reproduced or copied in an unauthorized manner. Such security paper shall include, at a minimum, but not limited to, the following security features:
1. A latent, repetitive pattern shall be visible across the entire front of the prescription blank if the prescription is scanned or photocopied; and
2. A chemical void protection that prevents alteration by chemical washing.
(w) Software. Programs, procedures and systems for receipt and/or storage of required information data.
(x) Stop Date. In institutional settings, the practitioner normally indicates on his/her drug order, the length of time to administer the medication. In absence of such a notation, a committee will have determined by policy, the length of time to administer the medication by category.

Rule 480-27-.02 Prescription Drug Order Requirements

(1) Prescription drug orders shall include, but not be limited to, the following information:
(a) Date of issue;
(b) Name and address of patient (or patient location if in an institution):
(c) Name and address of prescriber, telephone number, and NPI as assigned under federal law;
(d) DEA registration number of the prescriber in the case of controlled substances;
(e) Name, strength, dosage form and quantity of drug prescribed;
(f) Number of authorized refills;
(g) Directions for use by patient;
(h) If a written prescription drug order, the signature of the prescribing practitioner; and
(i) Any cautionary statements as may be required or necessary.
(2) Electronically transmitted prescription drug orders shall contain all information required for written prescriptions above and required by state and federal law including the prescriber's name, address, and phone number, except the signature may be an electronic signature as provided below and the electronically transmitted prescription must include the time and date of transmission.
(a) Electronically transmitted prescription drug orders transmitted from the practitioner and received by a pharmacy via facsimile must contain either an electronically reproduced visual image signature or original signature of the practitioner.
(b) Electronically generated prescription drug orders transmitted from the practitioner and received by a pharmacy as e-mails must contain an electronic data signature of the practitioner.
(c) All electronic prescription drug orders generated by a practitioner containing an electronically reproduced visual image signature or an electronic data signature must bear wording that appears on the face of the prescription which indicates the signature was electronically generated.
(3) The pharmacist shall exercise professional judgment regarding the accuracy and authenticity of prescriptions consistent with federal and state statutes and regulations. In the absence of unusual circumstances requiring further inquiry, the pharmacy and each of its associated pharmacists are entitled to rely on the accuracy and authenticity of electronically transmitted prescriptions from an intervening electronic for matter that comply with this rule.
(4) An electronic visual image prescription drug order that bears an electronic reproduction of the visual image of the practitioner's signature and is given directly to the patient must be printed on security paper with the wording that indicates the signature was electronically generated.
(a) Every hard copy prescription drug order for any Schedule II controlled substance written in this state by a practitioner shall be written on security paper. If a hard copy of an electronic data prescription drug order for any Schedule II controlled substance is given directly to the patient, the manually signed hard copy prescription drug order must be on security paper.
(5) Pharmacies are prohibited from receiving electronic data from intervening electronic for matters that do not meet all of the following requirements:
(a) Utilize recognized encrypted technology and secure servers.
(b) Maintain HIPAA compliance.
(c) Maintain a combination of technical and administrative security measures, such as, but not limited to those listed in Security Standards for the Protection of Electronic Protected Health Information (HIPAA), to ensure a reasonable and appropriate level of:
1. Practitioner and dispenser authentication;
2. Content integrity; and
3. Confidentiality.
(d) Refrain from collecting and disseminating patient and/or prescriber data to sources other than the originating prescriber and the receiving pharmacy.

Rule 480-27-.03 Records of Dispensing

Records of dispensing for original and refill prescriptions are to be made and kept by pharmacies for two years and shall include, but not be limited to:

(a) Quantities dispensed;
(b) Date of dispensing;
(c) Serial number (or equivalent if an institution);
(d) The identification of the pharmacist responsible for dispensing;
(e) Documentation of satisfaction of state requirements for drug product selection;
(f) Records of refills to date to include date(s) of refills, and identification of pharmacist(s) dispensing refills.

Rule 480-27-.04 Use of Facsimile Machine to Transmit or Recieve Prescription Drug Order

(1) All prescription drug orders sent via facsimile or other electronic means must meet the requirements of O.C.G.A. § 26-4-80 and Chapter 480-22 of the Board Rules and the requirements for electronically transmitted prescriptions or drug orders.
(2) All persons engaged in the practice of pharmacy in this state, which includes accepting or receiving a prescription drug order, must be licensed by the Board.
(3) All dangerous drugs and controlled substances must be dispensed pursuant only to a valid prescription drug order. A pharmacist shall not dispense a prescription drug order which the pharmacist knows or should know is not a valid prescription drug order.
(4) A prescription drug order may be accepted by a licensed pharmacist, a pharmacy intern or extern, acting under the direct supervision of a registered pharmacist, in written form, orally, via facsimile, or electronically as set forth in O.C.G.A. § 26-4-80 and the Rules of the Board. Provisions for accepting a prescription drug order for a schedule II controlled substance are set forth in Chapter 480-22.
(5) Prescription drug orders transmitted either electronically or via facsimile shall include the following requirements:
(a) Electronically transmitted prescription drug orders shall be transmitted directly by the prescribing practitioner or indirectly utilizing intervening electronic formatters as permitted under Georgia law, except in the case of a prescription drug order sent via facsimile equipment by the practitioner or the practitioner's agent acting under the direct supervision of the practitioner, to the pharmacy of the patient's choice with no other intervening person or intermediary having access to or retaining information contained in the prescription drug order. No patient or agent for a patient may transmit a prescription drug order to a pharmacy.
(b) Prescription drug orders transmitted or received by facsimile or other electronic means shall include:
1. In the case of a prescription drug order for a dangerous drug, the complete name, address and telephone number of the prescribing practitioner;
2. In the case of a prescription drug order for a controlled substance when authorized by federal law, the complete name, address, telephone number, and DEA registration number of the prescribing practitioner;
3. The complete name and address of the patient;
4. The time and date of transmission;
5. The complete name of the person transmitting the prescription drug order and a telephone number for verbal confirmation; and
6. The NPI for the prescriber as assigned under federal law; and
7. The practitioner's signature in the manner required in 480-27-.02(2).
(c) An electronically transmitted prescription drug order which meets the requirements of this Chapter shall be deemed sufficient to serve as the original prescription drug order for the pharmacy;
(d) Electronically generated prescriptions may be transmitted directly or indirectly thru one or more Intervening Electronic Formatters to a pharmacy's computer or other similar electronic device;
(e) Intervening electronic formatters not compliant with the requirements of this chapter will be considered an invalid source and are prohibited;
(f) Electronically generated prescriptions as e-mails directly from the prescriber to a pharmacy of the patient's choice shall be encrypted and accompanied by a digital ID for authentication purposes. The pharmacist shall exercise professional judgment regarding the accuracy and authenticity of prescriptions consistent with federal and state statutes and regulations. In the absence of unusual circumstances requiring further inquiry, the pharmacy and each of its associated pharmacists is entitled to rely on the accuracy and authenticity of electronically transmitted prescriptions. E-mail prescriptions should comply with the following:
1. E-mails shall be reduced to hard copy and maintained as a prescription order record and maintained as required by rules and statute for all other prescription orders; and
2. The prescription may not be for a controlled substance unless allowed by federal law.
(6) The pharmacist or pharmacy intern or extern acting under the direct supervision of a licensed pharmacist shall exercise professional judgment regarding the accuracy and authenticity of the transmitted prescription drug order consistent with Federal and State Laws and rules and regulations adopted pursuant to same.
(7) A prescription drug order electronically transmitted from a prescriber or a prescriber's agent acting under the direct supervision of the prescriber, shall be considered a highly confidential transaction and said transmission shall not be compromised by interventions, control, change, altering, or manipulation by any other person or party in any manner whatsoever except by an intervening electronic formatter as permitted by law and these rules.
(8) Any pharmacist or pharmacy intern or extern acting under the direct supervision of a licensed pharmacist that transmits, receives, or maintains any prescription or prescription refill either orally, in writing, or electronically shall ensure the security, integrity, and confidentiality of the prescription drug order and any information contained therein.
(9) The Board may provide exceptions to this Rule by establishing policies for institutional settings such as hospital pharmacies, nursing home pharmacies, outpatient clinic pharmacies, opioid treatment program clinic pharmacies, or pharmacies owned and operated directly by health maintenance organizations.
(10) Receiving computers or other similar electronic devices used to view the prescription shall be located within the pharmacy or pharmacy department with only authorized personnel having access.
(11) Transmission of prescriptions to answering machines and electronic voice recording devices by an authorized practitioner or approved agent shall be retrieved by a licensed pharmacist, intern, or extern and is considered to be a direct transmission of a prescription order.

Rule 480-27-.05 Record-Keeping When Utilizing an Automated Data Processing System

In order to comply with the record keeping requirements of this Chapter, an automated electronic data processing system may be utilized for the record keeping system if the following conditions have been met:

(a) Except as otherwise provided herein, all original prescriptions, those hard copies written by a practitioner, telephoned to the pharmacist by a practitioner and reduced to writing, or sent via facsimile machine or other electronic means must be retained as a permanent record for two years in the usual consecutively serial numbered prescription file. Any refill information subsequently authorized by a practitioner must be maintained in the manner required by O.C.G.A. § 26-4-80(e).
(b) The system shall at a minimum produce sight-readable records for all dangerous drug and controlled substance prescriptions filled or refilled during each 24 hour period. The term "sight-readable" means that a representative of the Board or GDNA shall be able to immediately retrieve and examine the record and read the information during any on-site visit to the pharmacy. For purposes of off-site audits and review, a separate copy of any sight-readable hard-copy printout or electronic readable file (such as a PDF file) of each daily record shall be made available to a representative of the Board of GDNA upon verbal request by that representative. These daily prescription records can:
1. Be generated as hard-copy print-outs at least once weekly, separated into each 24 hour period, by the pharmacy and maintained for at least two years after the last date on which the prescription was filled or refilled. If a hard-copy printout of each day's filled and refilled prescription is generated, that printout shall be verified, dated, and signed by the individual pharmacist who refilled such a prescription order. The individual pharmacist must verify that the data indicated are correct and then sign this document in the same manner as he would sign a check or legal document (e.g., J.H. Smith, or John H. Smith). This document shall be maintained in a separate file at that pharmacy for a period of two years from the dispensing date; or
2. Be maintained electronically. The computers on which the records are maintained may be located at another location, but the records must be immediately retrievable as hard-copy print-outs or viewing on a computer monitor set aside for such viewing at each individually registered pharmacy upon a verbal request by a representative from the Board or GDNA. The computer software must be capable of printing out or transferring the prescription records in a format that is readily understandable to the representative for the Board or GDNA at the registered location. Prescription records must also be sortable and retrievable by prescriber name, patient name, drug dispensed, and date filled. When utilizing electronic daily prescription fill and refill records, each pharmacy shall maintain a bound log book, or separate file, in which each individual pharmacist involved in such dispensing shall sign a statement each day, attesting to the fact that the prescription information entered by him or her into the computer that day has been reviewed by him or her and is correct as shown. Such a book or file must be maintained at the pharmacy employing such software for a period of two years after the date of dispensing the appropriately authorized refill.
(c) The information maintained by the automated electronic data processing system shall include, but not be limited to the following:
1. Date of dispensing;
2. Prescription number;
3. Patient's name;
4. Patient's address;
5. Drug name, strength and dosage form;
6. Quantity prescribed, and if the quantity dispensed is different from the quantity prescribed, the quantity dispensed;
7. Prescriber's name;
8. Identification of dispensing pharmacist;
9. Indication whether drugs are being dispensed pursuant to a new prescription or for a refill order;
10. In case of a controlled substance as allowed by federal law, the name, address and DEA registration of the practitioner and the schedule of the drug;
11. Directions for administration of the prescription to the patient;
12. Total number of refills authorized; and
13. NPI of the prescriber as assigned under federal law.
(d) Permanent records of electronic prescriptions for dangerous drugs and controlled substances do not have to be reduced to hard copy provided the following requirements are met:
1. Electronic prescription data must be maintained in the original format received for a minimum of two years; and
2. Reliable backup copies of the information are readily retrievable and stored in a secure and fireproof (minimum 1 hr UL approved) container, stored in a secured offsite location or backed up to a documented offsite secure storage device within 48 hours following each work day.
(e) The individual pharmacist responsible for completeness and accuracy of the entries to the system must provide documentation that prescription information entered into the computer is correct, by dating and signing the print-out in the same manner as signing a check or legal document (e.g., Mary A. Smith or M. A. Smith).
(f) An auxiliary record-keeping system shall be established for the documentation of filling new prescriptions, refills, and transfers if the automated electronic data processing system is inoperative for any reason. The auxiliary system shall insure that all refills are authorized by the original prescription and that the maximum number of refills is not exceeded. When this automated electronic data processing system is restored to operation, the information regarding prescriptions filled and refilled during the inoperative period shall be entered into the automated electronic data processing system as soon as possible. However, nothing in this section shall preclude the pharmacist from using his/her professional judgment for the benefit of a patient's health and safety.
(g) Any pharmacy using an automated electronic data processing system must comply with all applicable State and Federal laws and regulations.
(h) A pharmacy shall make arrangements with the supplier of data processing services or materials to insure that the pharmacy continues to have adequate and complete prescription and dispensing records if the relationship with such supplier terminates for any reason. A pharmacy shall insure continuity in the maintenance of records.

Rule 480-27-.06 Security

The computerized information provided by the system shall be used only by the pharmacy in which the data has been entered or a pharmacy sharing a common database. To maintain the confidentiality of patients' prescriptions, there must exist adequate safeguards or security of the records.

Rule 480-27-.07 Dangerous Prescription Drug Order Transfer

A pharmacy utilizing an automated electronic data processing system must satisfy all the information requirements as that used in a manual mode when transferring an original dangerous drug prescription drug order. The transfer of original prescription drug information for the purpose of refill dispensing is permissible between pharmacies subject to the following requirements:

(a) The prescription drug order is transmitted directly to the pharmacy of the patient's choice.
(b) The transfer is communicated directly between licensed pharmacists or licensed interns or externs under the direct supervision of a licensed pharmacist and the transferring pharmacist or intern or extern records the following information:
1. The word "VOID" is written on the face of the invalidated prescription drug order, and/or indicate in the pharmacy's electronic data system this prescription is void;
2. Record on the reverse of the invalidated prescription drug order the name and address of the pharmacy to which it was transferred and the name of the pharmacist or intern or extern under the direct supervision of a licensed pharmacist receiving the prescription drug order information, or have the electronic data system reflect the fact that the prescription drug order has been transferred, the name and address of the pharmacy to which it was transferred and the name of the pharmacist or intern or extern under the direct supervision of a licensed pharmacist to which it was transferred, and the date of the transfer; and
3. Record the date of the transfer and the name of the pharmacist or intern or extern under direct supervision of a licensed pharmacist transferring the information.
(c) The pharmacist or intern or extern under the direct supervision of a licensed pharmacist receiving the transferred prescription drug order shall reduce to writing, or cause the computer to reduce to writing, the following information which shall be filed as required by O.C.G.A. Title 16, Chapter 13 and Title 25, Chapter 4:
1. The word "TRANSFER" shall be written on the face of the transferred prescription and/or indicate in the pharmacy's electronic data system this prescription was a transfer;
2. All information required to be included on the prescription drug order pursuant to all State and Federal laws and regulations shall be provided which shall include at a minimum the following:
(i) Date of issuance of the original prescription drug order;
(ii) Original number of refills authorized on the original prescription drug order;
(iii) Date of original dispensing;
(iv) Number of valid refills remaining and date of last refill;
(v) The pharmacy's name, address, and original prescription serial number from which the prescription drug order information was transferred; and
(vi) Name of transferring pharmacist.
3. Both the original and transferred prescription must be maintained for a period of two years from the date of last refill.
(d) Pharmacies accessing a common electronic file or database used to maintain required dispensing information are not required to record on the original hard copy prescription drug order any information when transferring or refilling prescription drug orders as required for pharmacies not utilizing a common electronic file as noted in this Chapter. However, a hard copy of the prescription drug order must be generated and maintained by the pharmacist refilling or receiving the electronically transferred prescription drug order information. The common database must contain complete records of each prescription drug order transferred.

Rule 480-27-.08 Controlled Substance Prescription Drug Order Transfer

Pharmacies utilizing automated data processing systems must satisfy all information requirements of a manual mode for prescription transferal. The transfer of original prescription information for a controlled substance list in Schedules III, IV or V for the purpose of refill dispensing is permissible between pharmacies on a one-time basis only. Transfers are subject to the following requirements:

(a) The transfer is communicated directly between licensed pharmacists or intern or extern under the direct supervision of a licensed pharmacist, and the transferring pharmacist or intern or extern records the following information:
1. The word "VOID" is written on the face of the invalidated prescription drug order;
2. Record on the reverse side of the invalidated prescription drug order the name and address of the pharmacy to which it was transferred and the name of the pharmacist or intern or extern receiving the prescription drug order;
3. The date of the transfer and the name of the pharmacist or intern or extern transferring the information is recorded;
4. The computer record shall reflect the fact that the prescription drug order has been transferred, the name of the pharmacy to which it was transferred, and the date of the transfer, except as otherwise set forth in this Chapter relating to pharmacies utilizing common databases.
(b) The pharmacist or intern or extern receiving the transferred prescription information shall reduce to writing the following:
1. The word "TRANSFER" is written on the face of the transferred prescription drug order;
2. All information required to be on a prescription drug order pursuant to State and Federal laws and regulations shall be provided to the receiving pharmacist which shall include at a minimum the following:
(i) Date of issuance of the original prescription drug order;
(ii) Original number of refills authorized on the original prescription drug order;
(iii) Date of original dispensing;
(iv) Number of valid refills remaining and date of last refill;
(v) Pharmacy's name, address, DEA registration number, telephone number and original prescription drug order serial number from which the prescription information was transferred;
(vi) Name of transferring pharmacist or intern or extern.
(c) Both the original and transferred prescription drug order must be maintained for a period of two years from the date of last refill.
(d) Pharmacies accessing a common electronic file or database used to maintain required dispensing information are not required to record on the original prescription drug order any information when transferring or refilling prescription drug orders as required for pharmacies not utilizing a common electronic file as noted in this Chapter. A hard copy of the prescription drug order must be generated and maintained by the pharmacist refilling the electronically transferred prescription drug order. The common database must contain complete records of each prescription drug order transferred.

Rule 480-27-.09 Patient Records

(1) A patient record system shall be maintained by all pharmacies for patients for whom prescription drug orders are dispensed. The patient record system shall provide for the immediate retrieval of information necessary for the dispensing pharmacist to identify previously dispensed drugs at the time a prescription drug order is presented for filling or dispensing. The pharmacist shall make a reasonable effort to obtain, record, and maintain the following information:
(a) Full name of the patient for whom the drug is intended;
(b) Street address and telephone number of the patient;
(c) Patient's age or date of birth;
(d) The patient's gender;
(e) A list of all prescription drug orders obtained by the patient at the pharmacy maintaining the patient record during the two years immediately preceding the most recent entry showing the name of the drug, prescription number, name and strength of the drug, the quantity and date received, and the name of the practitioner; and
(f) Pharmacist comments relevant to the individual's drug therapy, including any other information peculiar to the specific patient or drug.
(2) The pharmacist shall make a reasonable effort to obtain from the patient or the patient's agent and shall record any known allergies, drug reactions, idiosyncrasies, and chronic conditions or disease states of the patient and the identity of any other drugs, including over-the-counter drugs or devices currently being used by the patient which may relate to prospective drug review.
(3) A patient record shall be maintained for a period of not less than five years from the date of the last entry in the profile record. This record may be a hard copy or a computerized form.

Rule 480-27-.10 Other Considerations

(1) All prescription drug orders lawfully authorized to be received via facsimile or other electronic means are allowed to serve as the original prescription drug order for the receiving pharmacy.
(2) No person or firm licensed under O.C.G.A. Title 26, Chapter 4 (the Georgia Pharmacy Practice Act) nor any other entity shall be permitted to provide facsimile machines or equipment, computer software, technology hardware, digital or electronic prescription drug order systems or supplies related to the transmission of prescription drug orders by electronic means to any practitioner which restricts such practitioner from issuing prescription drug orders for certain prescription drugs or restricts a patient from choosing the retail pharmacy to which an electronic prescription drug order maybe transmitted.
(3) A pharmacist or a pharmacy owner and/or manager that participates in any process which restricts the patient's freedom of choice is considered to have engaged in unprofessional conduct as defined by the Board's Rules.
(4) In compliance with O.C.G.A. Title 26, Chapter 4, no pharmacy or pharmacist may surrender copies of any patient's prescription drug order information or patient profile except under the following conditions:
(a) Written authority from the patient, the patient's caretaker, or a person with power of attorney for the patient;
(b) A subpoena or court order signed and issued by a government official or court;
(c) Any other person as authorized by O.C.G.A. § 26-4-80(d) to have access to the prescription; or
(d) A forged prescription drug order. Such forged prescription is considered evidence of a crime and should be surrendered to the proper law enforcement authority investigating such forgery. When turning over a forged prescription drug order to law enforcement officers, the officer should provide the pharmacy with a signed photocopy of the forged prescription drug order along with the name of the officer, his/her agency and telephone number.
(5) The receipt of, maintenance of, and dispensing pursuant to digital and electronic prescription drug orders in any manner other than as set forth in this chapter shall be considered a violation of the Board rules and regulations.
(6) Nothing in this rule is meant to supercede any U.S. Drug Enforcement Administration (DEA) laws or rules concerning the legality of transmission of or dispensing of controlled substance prescription drug orders bearing electronic or digital signatures.
(7) Nothing in this rule is meant to restrict compliance with e-prescribing as permitted under the Medicare Prescription Drug Improvement and Modernization Act of 2003.